ECSP941092A - DERIVATIVES OF TETRAHIDROPIRANO - Google Patents
DERIVATIVES OF TETRAHIDROPIRANOInfo
- Publication number
- ECSP941092A ECSP941092A ECSP941092A ECSP941092A EC SP941092 A ECSP941092 A EC SP941092A EC SP941092 A ECSP941092 A EC SP941092A EC SP941092 A ECSP941092 A EC SP941092A
- Authority
- EC
- Ecuador
- Prior art keywords
- derivatives
- tetrahidropirano
- inflammatory
- conditions
- agents
- Prior art date
Links
- 230000001506 immunosuppresive effect Effects 0.000 abstract 2
- 206010062016 Immunosuppression Diseases 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
- 229940041033 macrolides Drugs 0.000 abstract 1
- 150000003527 tetrahydropyrans Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere al campo de los macrólidos, especialmente a los derivados de tetrahidropirano. Esto se refiere más particularmente a los compuestos de la fórmula I. En donde los sustituyentes se definen en la especificación de la invención, los cuales son útiles como agentes antiinflamatorios o como agentes inmunosupresores y antiproliferativos, en el tratamiento de condiciones inflamatorios o hiperproliferativos, o de condiciones que requieren inmunosupresión.The present invention relates to the field of macrolides, especially tetrahydropyran derivatives. This refers more particularly to the compounds of formula I. Where the substituents are defined in the specification of the invention, which are useful as anti-inflammatory agents or as immunosuppressive and antiproliferative agents, in the treatment of inflammatory or hyperproliferative conditions, or of conditions that require immunosuppression.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310969A GB9310969D0 (en) | 1993-05-27 | 1993-05-27 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP941092A true ECSP941092A (en) | 1994-12-15 |
Family
ID=10736229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP941092 ECSP941092A (en) | 1993-05-27 | 1994-05-25 | DERIVATIVES OF TETRAHIDROPIRANO |
Country Status (4)
| Country | Link |
|---|---|
| EC (1) | ECSP941092A (en) |
| GB (1) | GB9310969D0 (en) |
| PL (1) | PL176409B1 (en) |
| TW (1) | TW324010B (en) |
-
1993
- 1993-05-27 GB GB939310969A patent/GB9310969D0/en active Pending
-
1994
- 1994-05-25 PL PL94303590A patent/PL176409B1/en not_active IP Right Cessation
- 1994-05-25 EC ECSP941092 patent/ECSP941092A/en unknown
- 1994-05-28 TW TW083104878A patent/TW324010B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| GB9310969D0 (en) | 1993-07-14 |
| TW324010B (en) | 1998-01-01 |
| PL176409B1 (en) | 1999-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2154720T3 (en) | HETEROCICLIC ESTERS OF RAPAMYCIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MX9300498A (en) | DERIVATIVES OF N-SULFONIL-2-OXO-INDOL, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| AR002740A1 (en) | COMPOUND DERIVED FROM ISOTIAZOLONE AND PHARMACEUTICAL FORMULATION WITH THE SAME. | |
| ES2085876T3 (en) | DERIVATIVE OF BIPHENYLMETHANE, ITS USE AND PHARMACOLOGICAL COMPOSITIONS THAT CONTAIN THE SAME. | |
| DK0618190T3 (en) | 9- (Substituted glycyl) amido-6- (substituted) -5-hydroxy-6-deoxy-tetracyclines | |
| ATE334969T1 (en) | TRIPTOLIDE PRODRUGS WITH HIGH WATER SOLUBILITY | |
| MX9304698A (en) | HETERO CYCLES CONTAINING SUBSTITUTED NITROGEN. | |
| DE69330852D1 (en) | 7- (Substituted) -8- (substituted) -9- (substituted glycyl) amido-6-demethyl-6-deoxytetracycline | |
| GB9508195D0 (en) | Novel biologically active compounds and compositions,their use and derivation | |
| ES2171428T3 (en) | DERIVATIVES OF GALANTAMINE, A PROCEDURE FOR ITS PREPARATION AND ITS USE AS MEDICATIONS. | |
| ES2138622T3 (en) | DERIVATIVES OF MERCAPTOACETILAMIDO PIRIDAZO (1,2-A) (1,2) DIAZEPINA USED AS ENCEPHALINASE AND ECA INHIBITORS. | |
| ES2096639T3 (en) | DERIVATIVES OF BENZOFURANO, BENZOTIOFENO, INDOL OR INDOLIZINA, ITS PREPARATION PROCEDURE, AS WELL AS THE COMPOSITIONS THAT CONTAIN THEM. | |
| DE60215656D1 (en) | PHOTOSTABILE ORGANIC SUN PROTECTION AGENTS WITH ANTIOXIDATIVE PROPERTIES AND COMPOSITIONS THEREWITH | |
| ES2098004T3 (en) | PEPTIDES DERIVED FROM TRIFLUORO-METHYL-KETONES WITH AN INHIBITING ACTIVITY OF HUMAN LEUKOCITARY ELASTASE (HLE), ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| ES2085726T3 (en) | PROLINIC DERIVATIVE OF RAPAMICINE, ITS PRODUCTION AND APPLICATION. | |
| ES2150152T3 (en) | NOVEL STEROID NITRITE / NITRATE ESTER DERIVATIVES USEFUL AS ANTI-INFLAMMATORY PHARMACES. | |
| ES2096941T3 (en) | 27-HYDROXIRRAPAMICINA AND DERIVATIVES OF THE SAME. | |
| ES2150705T3 (en) | USEFUL STEROID NITRITE ESTER DERIVATIVES AS ANTI-INFLAMMATORY PHARMACES. | |
| ES2120037T3 (en) | 1-PHENYL- OR 1-PIRIDINYL-BENZOTRIAZOLES SUBSTITUTED HERBICIDES. | |
| MX9306666A (en) | NEW AZETIDINONES SUBSTITUTED AS ANTI-INFLAMMATORY AND ANTI-DEGENERATIVE AGENTS. | |
| AR024747A1 (en) | DERIVATIVES OF AMINOTIAZOLES, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| MX9305093A (en) | NEW DERIVATIVESINDANO-2 MERCAPTOACETILAMINA TRICICLICOS 2-SUBSTITUTED, USEFUL AS ENCEPHALINASE INHIBITORS. | |
| ES2064119T3 (en) | NEW DERIVATIVES OF AMINOBENZOSULTAM AS LIPOXIGENASE INHIBITORS. | |
| ECSP941092A (en) | DERIVATIVES OF TETRAHIDROPIRANO | |
| PT679082E (en) | C10 TAXAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS |